Recent News

Latest GeoVax News

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
213
ATLANTA, GA, August 14, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human immunotherapies and vaccines, today announced its financial results for the...
Last modified on Continue reading
1106
Updates Provided on Financial Status and Development Programs ATLANTA, GA, August 2, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines and...
Last modified on Continue reading
1570
Company Offers Novel Ebola Vaccine for Public Health Use…Gratis ATLANTA, GA, July 30, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines...
Last modified on Continue reading
1612
Study Data Adds to Similar Efficacy Previously Reported for  GeoVax’s Ebola and Lassa Fever Vaccines ATLANTA, GA, July 29, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX), a...
Last modified on Continue reading
580
Presentation Made at the 10th International AIDS Society Conference on HIV Science ATLANTA, GA, July 24, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company...
Last modified on Continue reading